LIMIT-2(redirected from Leicester Intravenous Magnesium Intervention II Trial)
Conclusion While the findings are controversial, LIMIT-2 data indicate that 24-hour IV magnesium sulfate infusion is associated with a 25% decreased mortality
LIMIT-2Cardiology A clinical trial–Leicester Intravenous Magnesium Intervention Trial-2— that evaluated the effect of IV magnesium sulfate
on survivors of acute MI. See Acute myocardial infarction, Magnesium sulfate. Cf ISIS-4.